Being first out of the starting gate with research counts. Investigators from Brigham and Women’s Hospital are the first to report that ordinary layered clay—scientific term “synthetic silicate nanoplatelets”—can induce stem cells to become bone cells without the need of additional bone-inducing factors. They published their results online in Advanced Materials.
Humble Clay Induces Stem Cell Change

Synthetic silicates are made up of simple or complex salts of silicic acids, and have been used extensively in commercial applications such as in food additives, glass and ceramic filler materials, and anti-caking agents.
“Based on the strong preliminary studies, we believe that these highly bioactive nanoplatelets may be utilized to develop devices such as injectable tissue repair matrixes, bioactive fillers, or therapeutic agents for stimulating specific cellular responses in bone-related tissue engineering, ” said Akhilesh Gaharwar, Ph.D., BWH Division of Biomedical Engineering, the first study author.
His colleague, Ali Khademhosseini, Ph.D., also of BWH Division of Biomedical Engineering and the senior study author, added, “With an aging population in the U.S., injuries and degenerative conditions are subsequently on the rise. As a result, there is an increased demand for therapies that can repair damaged tissues. In particular, there is a great need for new materials that can direct stem cell differentiation and facilitate functional tissue formation. Silicate nanoplatelets have the potential to address this need in medicine and biotechnology.”

Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.